DCGO Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
73.4M
+0.0%
73.4M
-2.8%
75.6M
+0.8%
74.9M
+5.8%
70.8M
Cost of Revenue
49.0M
-4.0%
51.0M
-1.3%
51.7M
+2.2%
50.6M
-4.0%
52.7M
Gross Profit
24.5M
+9.2%
22.4M
-6.2%
23.9M
-2.0%
24.4M
+34.4%
18.1M
Operating Expenses
41.7M
+3.5%
40.3M
-5.3%
42.6M
-67.0%
128.9M
+114.5%
60.1M
R&D
4.0M
+16.8%
3.4M
-7.0%
3.7M
-1.8%
3.8M
+18.1%
3.2M
SG&A
29.3M
-2.7%
30.2M
-3.3%
31.2M
-21.1%
39.6M
+29.8%
30.5M
Operating Income
-17283397
+3.6%
-17922223
+4.2%
-18711091
+82.1%
-104579509
-149.1%
-41976309
EBITDA
-10281763
+18.4%
-12596113
-1.7%
-12389410
+39.1%
-20348494
-21.0%
-16812044
Net Income
-18292043
-1.7%
-17992298
-7.7%
-16699837
+88.3%
-142340600
-380.0%
-29657362
EPS (Basic)
$-0.17
-6.3%
$-0.16
-6.7%
$-0.15
+89.1%
$-1.37
-389.3%
$-0.28
EPS (Diluted)
$-0.17
-6.3%
$-0.16
-6.7%
$-0.15
+89.1%
$-1.37
-389.3%
$-0.28
Shares (Diluted)
98.9M
+0.1%
98.8M
+0.1%
98.7M
+0.8%
97.9M
+0.1%
97.8M
DocGo (DCGO) — Financials